Mobile Navigation

Sustainability

View Comments

TotalEnergies signs Renewable Power Purchase Agreements with Sasol and Air Liquide

| By Mary Bailey

TotalEnergies SA (Paris, France) has signed Corporate Power Purchase Agreements (CPPA) with Sasol Ltd. (Johannesburg, South Africa) and Air Liquide Large Industries South Africa for the supply of 260 MW capacity of renewable electricity over 20 years. 

TotalEnergies will develop a 120 MW solar plant and a 140 MW windfarm in the Northern Cape province to supply around 850 GWh of green electricity per year to the Sasol’s Secunda site, located 700 kilometers further North-East, where Air Liquide operates the biggest oxygen production site in the world.

Earlier this year, air Liquide and Sasol signed Power Purchase Agreements with Enel Green Power (Rome, Italy) for 220 MW of renewable power to the Secunda site.

The two projects will provide competitive and available renewable electricity to decarbonize Sasol and Air Liquide’s production. These agreements demonstrate TotalEnergies’ positioning to contribute to the evolution of the energy mix in South Africa. The projects will have a direct impact on the local community through job creations.

“Power generation in South Africa is still 80% based on coal and power cuts occur daily.  With these developments we are proud to support Air Liquide and Sasol for their supply of green electricity. Meanwhile, we are pleased to contribute to South Africa’s energy transition which consists of increasing its share of renewables and gas as an alternative to coal” said Vincent Stoquart, Senior Vice President, Renewables at TotalEnergies. “There is a dynamic market for corporate PPAs in South Africa and we want TotalEnergies to take a strong leadership position.”

The two projects are expected to be operational in 2025. The CPPAs with SASOL and Air Liquide were signed with a consortium of TotalEnergies Marketing South Africa1  (70%), its partner Mulilo (17%) and a to-be-announced B-BBEE partner (13%).

These projects are subject to regulatory approvals.